Robert Nicholas was quoted in the Boston Globe on March 2 regarding the FDA asking Congress to give it more powers to dictate the warnings on drug labels. The FDA has strong authority to dictate labeling language before a drug is approved. "Once a product is on the market, it's like a property right," commented Bob. The FDA still has negotiating clout because if a drug company refuses its suggestions the agency could initiate legal proceedings to remove the drug from the market or it could ask the secretary of the DHHS to declare a drug an imminent hazard. "There are lots of informal rules -- there is jawboning and discussions," Mr. Nicholas said.